6 results match your criteria: "COVID-19 Vaccine Safety Research Center[Affiliation]"
J Korean Med Sci
November 2024
COVID-19 Vaccine Safety Research Center, Seoul, Korea.
The emergence of the omicron variant and its sub-lineages has necessitated vaccine updates for coronavirus disease 2019. In September 2023, the U.S.
View Article and Find Full Text PDFJ Korean Med Sci
November 2024
COVID-19 Vaccine Safety Research Center, Seoul, Korea.
Osong Public Health Res Perspect
April 2024
COVID-19 Vaccine Safety Research Center, Seoul, Republic of Korea.
This systematic review evaluated psychiatric adverse events (AEs) following vaccination against coronavirus disease 2019 (COVID-19). We included studies that reported or investigated psychiatric AEs in individuals who had received an approved COVID-19 vaccine in the Republic of Korea. Systematic electronic searches of Ovid-Medline, Embase, CENTRAL, and KoreaMed databases were conducted on March 22, 2023.
View Article and Find Full Text PDFOsong Public Health Res Perspect
April 2024
COVID-19 Vaccine Safety Research Center, Seoul, Republic of Korea.
Osong Public Health Res Perspect
February 2023
COVID-19 Vaccine Safety Research Center, Seoul, Korea.
With the introduction of coronavirus disease 2019 (COVID-19) vaccines, the Korea Disease Control and Prevention Agency (KDCA) commissioned the National Academy of Medicine of Korea to gather experts to independently assess post-vaccination adverse events. Accordingly, the COVID-19 Vaccine Safety Research Committee (CoVaSC) was launched in November 2021 to perform safety studies and establish evidence for policy guidance. The CoVaSC established 3 committees for epidemiology, clinical research, and communication.
View Article and Find Full Text PDF